Skip to main content

Displaying 1201 - 1220 of 1511

SPA Health Organization, d/b/a Southwest Physician Associates, In the Matter of

A physician group in the Dallas/Fort Worth, Texas area settled charges that it collectively bargained on behalf of its members to negotiate fee schedules with third party payers and other health insurance companies. According to the complaint, issued with the consent order, these practices decreased competition and increased prices for the provision of medical services to area consumers.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
011 0197
Docket Number
C-4088

Anesthesia Service Medical Group, Inc.

Two anesthesiologists groups settled charges that they entered into joint agreements to establish fees and services from Grossmont Medical Hospital in San Diego County. Specifically, the groups agreed on fees that both would demand from health care insurance companies and other third party payers for taking call for obstetrics and providing services to uninsured emergency room patients. Together, the two groups are composed of approximately 200 physicians that provide competing anesthesiology services in the San Diego area.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0210006
Docket Number
C-4085

Announced Actions for July 15, 2003

Date
Following a public comment period, the Commission has approved the issuance of two final consent orders in the matters concerning Anesthesia Service Medical Group, Inc. and Grossmont Anesthesia...

Carlsbad Physician Association, Inc.; and William J. Baggs, M.D.; Srichand S. Dara, M.D.; Glen Moore; James J. Purpura, D.O.; Deborah J. Schenck, M.D.; Charles L. Secora, M.D.; Majid A. Syed, M.D.; and Richard L. Zizza, M.D

A New Mexico physician organization settled charges that it and its members entered into agreements to fix prices and to refuse to deal with third party payers and other health care plans except on collectively agreed-upon terms.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0310002
Docket Number
C-4081

Pfizer Inc. and Pharmacia Corporation

A final consent order permits Pfizer Inc.'s acquisition of Phamacia Corporation while requiring the divestiture of various products including extended release drugs used in the treatment of an overactive bladder; hormone replacement therapies; erectile dysfunction; canine arthritis; and motion sickness. Novartis AG, Neurocrine Biosciences, Inc., Schering-Plough Corporation, Johnson & Johnson, Insight Pharmaceuticals Corporation, and Cadbury Schweppes are named in the order as potential buyers of the various pharmaceuticals and products.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
021 0192
Docket Number
C-4075